SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Transformation to pure-play Innovative Medicines company nears completion
The ANDA was filed as 'First to File' submission on NCE-1 date.
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
Subscribe To Our Newsletter & Stay Updated